Medtronic To Seek HDE For Activa To Treat Obsessive-Compulsive Disorder

Medtronic's pursuit of Activa deep-brain stimulation to treat chronic obsessive-compulsive disorder will serve as a springboard to the lucrative depression market, the company predicts

More from Archive

More from Medtech Insight